| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.0M | -15.0% |
| Cost of Revenue | $33.6M | -16.4% |
| Gross Profit | $22.4M | -12.8% |
| R&D Expense | $3.8M | -33.2% |
| SG&A Expense | $6.9M | -20.1% |
| Operating Income | -$20.9M | -69.8% |
| Pre-tax Income | -$25.7M | +51.4% |
| Income Tax | $1.1M | +294.5% |
| Net Income | -$26.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -78.7% |
| Accounts Receivable | $1.1M | +25.3% |
| Current Assets | $95.4M | +6.1% |
| Total Assets | $122.3M | -5.0% |
| Current Liabilities | $103.5M | +21.0% |
| Long-term Debt | $17.4M | +9.1% |
| Total Liabilities | $123.8M | +17.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.2M | -36.1% |
| Capital Expenditures | $47K | -56.5% |
| Investing Cash Flow | -$1.8M | -179.1% |
| Financing Cash Flow | -$241K | +92.0% |
| Free Cash Flow | $21.1M | -36.0% |
| +49.5% |
| EPS (Basic) | -$4.01 | +60.3% |
| EPS (Diluted) | -$4.01 | +60.3% |
| Stockholders' Equity |
| -$1.5M |
| -106.4% |